BODI
Beachbody Company, Inc.$4.01 −0.16 (−3.84%)
Oct 27 4:00 PM ET · prev $4.17
Market cap
$30.9M
Nano cap
Median target
$18.50
+361% · range $9.00–22.00
Next earnings
Nov 16
in 19 days · EPS est. −$0.03
1 year
−18.8%
from $4.94 · Oct 28
30 days
−15.3%
from $4.74
52-week range
$4.01–16.05
at the low
Avg volume 20D
13.6K
Oct 8 spike 44.7K
Short interest
175.9K
≈2.4% of shares · −0.7%
Days to cover
12.2
at average volume
Insider net
$0
no open-market trades · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
1
analyzed by SecBot
SecBot read MIXED 1 report · 90 days
Balance 0 bearish · 0 bullish · 1 mixed oldest → newest, height = score
Avg score ·High conf. 1/1 ·Next Earnings date, Nov 16, 2026
Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
No data for this timeframe.
Signal stack
Where each data set points today.
- InsidersNO TRADES
No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.
- InstitutionsBULLISH
Q2 2026: 6 added (0 new), 2 trimmed or exited.
- Short sellersSTEADY
Short interest −0.7% to 175.9K shares. 12.2 days to cover, ≈2.4% of shares.
- TrendDOWNTREND
22% below its 50-day average. New closing low $4.01 on Oct 27.
Who's buying
13F· Q2 20260
new positions
0
exits
| Fund | Move | Value |
|---|---|---|
| ROYAL BANK OF CANADA | DOUBLED | Not reported |
| BlackRock, Inc. | ADD | $798.4K |
| CITADEL ADVISORS LLC | DOUBLED | $383.6K |
| DIMENSIONAL FUND ADVISORS LP | DOUBLED | $294.4K |
| UBS Group AG | DOUBLED | $156.2K |
| Trexquant Investment LP | TRIM | $130.6K |
| BNP PARIBAS FINANCIAL MARKETS | DOUBLED | $9.3K |
| WELLS FARGO & COMPANY/MN | TRIM | $235.00 |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
last action May 202612-month targets · 4 analysts
$4.01 $9.00 $18.50 $22.00
Price is below the lowest target. Median implies +361%.Targets as of Oct 28, 2026.
Recent actions
| Date | Firm | Rating |
|---|---|---|
| May 5, 2026 | Canaccord Genuity MAINTAIN | Buy |
Washington
Insider ledger
Form 4$0
open-market buys or sells · 12 mo
| Date | Insider | Type | Value |
|---|---|---|---|
| Aug 15, 2026 | GOLDSTON MARK R Executive Chairman | AWARD | 100,000 sh |
| Aug 15, 2026 | Ramberg Bradley SEE REMARKS | AWARD | 3,556 sh |
| Jul 15, 2026 | Ramberg Bradley SEE REMARKS | TAX W/H | $599.40 |
| Jun 2, 2026 | Heller Michael Director | AWARD | 9,182 sh |
| Jun 2, 2026 | Conlin Mary Murphy Director | AWARD | 9,182 sh |
| Jun 2, 2026 | Salter John S. Director | AWARD | 9,182 sh |
| Jun 2, 2026 | Frank Kristin E. Director | AWARD | 9,182 sh |
| Jun 2, 2026 | Mayer Kevin A Director | AWARD | 9,182 sh |
Earnings setup
EstimatesNov 16
reports in 19 days
−$0.03
EPS estimate, this quarter
Current-quarter EPS estimate
$0.00090d
$0.00060d
$0.00030d
$0.0007d
−$0.030Now
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | -$0.03 | -$0.03–-$0.03 | No data | $46.3M |
| Next Q | $0.24 | $0.24–$0.24 | No data | $47.4M |
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | $1.57 | $1.57–$1.57 | No data | $221.5M |
Short side
FINRA· Oct 15, 2026175,870
shares short
-0.7%
vs prior settlement
12.2
days to cover
≈2.4%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Aug 15, 2026 Insider
GOLDSTON MARK R was granted 100,000 shares
Executive Chairman
Aug 15, 2026 Insider
Aug 10, 2026 SEC Ramberg Bradley was granted 3,556 shares
SEE REMARKS
Beachbody reported Q2 2026 revenue of $49.6M (-22.4% YoY), beating consensus of $49.3M by 0.6%, with GAAP basic EPS of…
8-K · Impact 5/10
Aug 10, 2026 Earnings calendar
BODI Q2 2026 Earnings Scheduled — 2026-08-10
Jul 15, 2026 Insider
Ramberg Bradley surrendered for taxes 54 shares
SEE REMARKS @ $11.10 ($599.40)
Jun 30, 2026 Inst.
ROYAL BANK OF CANADA · DOUBLED
39 shares
Jun 30, 2026 Inst.
BlackRock, Inc. · ADD
78,117 shares ($798.4K)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Recent
Aug 10, 2026
Earnings date
BODI Q2 2026 Earnings Scheduled — 2026-08-10
Aug 3, 2026
Earnings date
BODI Q2 2026 Earnings Scheduled — 2026-08-03
May 12, 2026
Earnings date
BODI Q1 2026 Earnings Scheduled — 2026-05-12
May 11, 2026
Earnings date
BODI Q1 2026 Earnings Scheduled — 2026-05-11
Apr 12, 2026
Trial readout
T-90d Trial Readout: rAAV2tYF-GRK1-hRPGRco (Phase 3)
Trial: A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With XLRP Sponsor: Beacon…
SecBot reports
1 filing · 0 bullish · 0 bearish · 1 mixedAll BODI filing & press-release reports (1)
- 8-K reportAug 10, 2026